These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38916702)

  • 1. Dry eye and decreased tear film stability in primary acquired nasolacrimal duct obstruction patients.
    Yu X; Wang K; Hu Y; Meng Z; Li J; Liu Y; Xiao L; Chen M; Li S; Shen Y; Chen R; Liang X
    Int Ophthalmol; 2024 Jun; 44(1):277. PubMed ID: 38916702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced tear break-up time in the fellow eye of patients with unilateral primary acquired nasolacrimal duct obstruction.
    Tıskaoğlu NS; Yazıcı A
    Int Ophthalmol; 2023 Mar; 43(3):965-971. PubMed ID: 36053478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in the meibomian glands in postmenopausal women with primary acquired nasolacrimal duct obstruction: a prospective study.
    Jin H; Zhang H
    BMC Ophthalmol; 2023 Feb; 23(1):48. PubMed ID: 36726065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tear instability in the fellow eye of unilateral nasolacrimal obstruction and resolution with dacryocystorhinostomy.
    Tıskaoğlu NS; Yazıcı A
    Orbit; 2023 Aug; 42(4):404-410. PubMed ID: 36069079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Videoreflective dacryomeniscometry in normal adults and in patients with functional or primary acquired nasolacrimal duct obstruction.
    Francis IC; Chan DG; Papalkar D; Papas EB; Stapleton F
    Am J Ophthalmol; 2005 Mar; 139(3):493-7. PubMed ID: 15767059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alteration of Tear Cytokine Expressions in Primary Acquired Nasolacrimal Duct Obstruction - Potential Insights into the Etiopathogenesis.
    Ali MJ; Patnaik S; Kelkar N; Ali MH; Kaur I
    Curr Eye Res; 2020 Apr; 45(4):435-439. PubMed ID: 31490706
    [No Abstract]   [Full Text] [Related]  

  • 7. Lacrimal gland activity in lacrimal drainage obstruction: exploring the potential cross-talk between the tear secretion and outflow.
    Singh S; Srivastav S; Bothra N; Paulsen F; Ali MJ
    Br J Ophthalmol; 2024 Mar; 108(4):621-624. PubMed ID: 37142331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tear meniscus measurement in nasolacrimal duct obstruction patients with Fourier-domain optical coherence tomography: novel three-point capture method.
    Park DI; Lew H; Lee SY
    Acta Ophthalmol; 2012 Dec; 90(8):783-7. PubMed ID: 21726426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meibomian Gland Dysfunction in Primary Acquired Nasolacrimal Duct Obstruction.
    Yoon S; Lee H; Baek S
    J Craniofac Surg; 2023 Jun; 34(4):e395-e398. PubMed ID: 37157128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dry Eye Assessment of Patients Undergoing Endoscopic Dacryocystorhinostomy for Nasolacrimal Duct Obstruction Combined with Dry Eye Syndrome.
    Kim MH; Lee K; Chang M
    Korean J Ophthalmol; 2023 Oct; 37(5):395-400. PubMed ID: 37621092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphometric Evaluation of Bony Nasolacrimal Canal in a Caucasian Population with Primary Acquired Nasolacrimal Duct Obstruction: A Multidetector Computed Tomography Study.
    Bulbul E; Yazici A; Yanik B; Yazici H; Demirpolat G
    Korean J Radiol; 2016; 17(2):271-6. PubMed ID: 26957913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lacrimal Gland Volume Changes in Unilateral Primary Acquired Nasolacrimal Obstruction.
    Yazici A; Bulbul E; Yazici H; Sari E; Tiskaoglu N; Yanik B; Ermis S
    Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4425-9. PubMed ID: 26193918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective controlled study of vapor pressure tear osmolality and tear meniscus height in nasolacrimal duct obstruction.
    Stahl U; Francis IC; Stapleton F
    Am J Ophthalmol; 2006 Jun; 141(6):1051-6. PubMed ID: 16765672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrolytes and electrophoretic studies of tear proteins in tears of patients with nasolacrimal duct obstruction.
    Lew H; Yun YS; Lee SY
    Ophthalmologica; 2005; 219(3):142-6. PubMed ID: 15947499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conjunctival cytologic features in patients with unilateral primary acquired nasolacrimal duct obstruction.
    Yuksel N; Mutlu M; Kilicarslan A; Akcay E
    Int Ophthalmol; 2018 Feb; 38(1):323-326. PubMed ID: 28224303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-regurgitation on pressure over lacrimal sac in cases of primary-acquired nasolacrimal duct obstruction: Correlation with physician examination and patients' perceptions.
    Alam MS; Singh P; Amitava AK; Ali MJ
    Saudi J Ophthalmol; 2021; 35(3):217-219. PubMed ID: 35601852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Micro-Reflux Test: a new test to evaluate nasolacrimal duct obstruction.
    Camara JG; Santiago MD; Rodriguez RE; Medalle RA; Young DA; Atebara NH
    Ophthalmology; 1999 Dec; 106(12):2319-21. PubMed ID: 10599664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tear-Film Osmolarity Changes Following Dacryocystorhinostomy in Primary Acquired Nasolacrimal Duct Obstruction.
    Yuksel N; Akcay E; Ayan B; Duru N
    Curr Eye Res; 2017 Mar; 42(3):348-350. PubMed ID: 27419611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic analysis of 166 patients with primary acquired nasolacrimal duct obstruction.
    Lee-Wing MW; Ashenhurst ME
    Ophthalmology; 2001 Nov; 108(11):2038-40. PubMed ID: 11713075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship between Primary Acquired Nasolacrimal Duct Obstruction and Gastroesophageal Reflux.
    Owji N; Radaei M; Khademi B
    Curr Eye Res; 2018 Oct; 43(10):1239-1243. PubMed ID: 29897254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.